QS Investors’s Guardant Health GH Stock Holding History

QS Investors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,200	Closed	-$84K	–	1666
2020 Q1	$84K	Buy	+1,200	New	+$92.1K	﹤0.01%	1302

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

QS Investors's GH Position: Q2 2020 in Review

QS Investors sold out of Guardant Health (GH) in Q2 2020, closing a stake of 1,200 shares — an estimated $84K sold.

QS Investors first reported a position in GH in Q1 2020 and held it in 1 quarter. The position peaked at $84K in Q1 2020. 325 funds tracked by Wall St. Rank hold GH as of Q2 2020.

QS Investors reported no remaining Guardant Health position as of Q2 2020 after selling out during the quarter.
QS Investors sold 1,200 Guardant Health shares in Q2 2020, an estimated $84K.
QS Investors first reported a position in Guardant Health in Q1 2020 and held it in 1 quarter.
QS Investors's Guardant Health position peaked at $84K in Q1 2020.
325 funds tracked by Wall St. Rank held Guardant Health as of Q2 2020.

Based on QS Investors's 13F filing for Q2 2020, filed 14 Aug 2020.